000023438 000__ 01782cam\a22003735i\4500
000023438 001__ 23438
000023438 003__ SzGeWIPO
000023438 005__ 20240708161938.0
000023438 008__ 990929s1999\\\\xx\\\\\\r\\\\u000\0\eng\d
000023438 035__ $$a(wipo)(CD )99-1883
000023438 035__ $$a(OCoLC)1159940754
000023438 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000023438 043__ $$ae------
000023438 084__ $$aG 51 GB 110
000023438 090__ $$c25613$$d25613
000023438 1001_ $$aJones, Nigel,$$eauthor.
000023438 24510 $$aRegulation and patenting :$$bEuropean harmonisation /$$cNigel Jones.
000023438 264_1 $$a[Place of publication not identified] :$$b[publisher not identified],$$c1999.
000023438 300__ $$a1 volume ([7] pages) ;$$c[28] cm.
000023438 336__ $$atext$$btxt$$2rdacontent
000023438 337__ $$aunmediated$$bn$$2rdamedia
000023438 338__ $$avolume$$bnc$$2rdacarrier
000023438 4901_ $$aBio-Science Law Review ;$$v1998/1999 No 6 pages 203-210
000023438 500__ $$a"The European Commission has tried to achieve a 'single market' in many industrial sectors in Europe. It faces particular challenges in relation to pharmaceuticals. This article considers the Commission's achievements to date in relation to the regulatory regime and patent law in this sector, and considers how things are likely to change in the future."
000023438 650_0 $$aPatents$$zEurope.
000023438 650_4 $$aPHARMACEUTICAL PRODUCTS : REGULATORY REGIME : EUROPEAN COMMUNITY
000023438 650_4 $$aPATENTS : SCOPE AND MAINTENANCE OF RIGHTS : HARMONIZATION OF PATENTS : EUROPEAN COMMUNITY
000023438 650_4 $$aPHARMACEUTICAL INDUSTRY : HARMONIZATION OF MARKET : EUROPEAN COMMUNITY
000023438 651_0 $$aEurope$$xCommerce$$xLaw and legislation.
000023438 830_0 $$aBio-Science Law Review ;$$v1998/1999 No 6 pages 203-210.
000023438 903__ $$v1$$aBIO-SCIENCE LAW REVIEW
000023438 904__ $$aJournal article
000023438 942__ $$cART
000023438 952__ $$w2006-11-03$$p1999-1883$$r0.00$$u36842$$bMAIN$$10$$kG 51 GB 110$$v1999-09-29$$zMISSING$$70
000023438 980__ $$aBIB
000023438 999__ $$c25613$$d25613